Items Tagged ‘PARP Inhibitors’

May 16, 2018

PARP – Checkpoint Inhibitor Combo Promising in Ovarian Cancer

By

CancerConnect News: The combination of a PARP inhibitor and a checkpoint inhibitor appears promising as treatment for patients with ovarian cancer, according to results of a clinical study reported at the 2018 Society for Gynecologic Oncology Annual Meeting on Women’s Cancer in New Orleans, Louisiana.  Preliminary results from the study suggest that the combination could provide meaningful […]

View full entry

Tags: checkpoint inhibitor, News, Ovarian Cancer, PARP Inhibitors, PD-1, Precision Cancer Medicine


January 15, 2018

Lynparza Slows Spread of Inherited Breast Cancer Caused by BRCA Mutations: First Drug Approved for BRCA Breast Cancer

By

CancerConnect News: The US Food and Drug Administration (FDA) has extended the approval of Lynparza (olaparib) to include the treatment of metastatic breast cancer in patients who carry the specific inherited BRCA mutation.  These patients can be identified by using the FDA-approved genetic test, BRACAnalysis CDx (Myriad Genetic Laboratories). About BRCA Breast Cancer Breast cancer […]

View full entry

Tags: brca, Breast Cancer, clinical trial, lynparza, News, olaparib, OlympiAD, PARP Inhibitors